Life :: Scientists find new way to search for origin of life – DNA microarray technology

Over the last half century, researchers have found that mineral surfaces may have played critical roles organizing, or activating, molecules that would become essential ingredients to all life–such as amino acids (the building blocks of proteins) and nucleic acids (the essence of DNA). But which of the countless possible combinations of biomolecules and mineral surfaces were key to this evolution? This vexing question has stumped scientists for years because of the sheer volume of possibilities.

Depression :: New depression model advances disease frontiers – CAMH

For over 30 years, scientists believed that monoamines are low in the brain during major depressive episodes. However, no one ever found a convincing explanation for monoamine loss. Dr. Jeffrey Meyer and colleagues discovered that higher levels of MAO-A is the primary process that lowers monoamine levels. Having more MAO-A leads to greater breakdown of chemicals like serotonin. Based on these results, and work from previous publications, Dr. Meyer developed an advanced monoamine model of depression.

Eating Disorders :: Patient’s Worldwide Bill of Rights for Eating Disorders Demands Proof of Results

An international professional society has issued a patient?s bill of rights for the treatment of eating disorders, conditions that affect an estimated 30 million Americans, most of them young women. For 2 million, symptoms will progress to full-blown anorexia nervosa and approximately 10 percent will die from the disease. Treatment is often complex and typically involves not only the patient, but friends and family as well.

Osteosarcoma :: IDM Pharma’s Mepact, mifamurtide – Junovan in the Treatment of Osteosarcoma

IDM Pharma (NASDAQ:IDMI) announced today that the company has submitted a Marketing Authorization Application (MAA) in eCTD format (electronic common technical document) to the European Medicines Agency (EMEA) for Mepact (mifamurtide for injection), requesting approval for its use in the treatment of patients with newly diagnosed resectable high-grade osteosarcoma following surgical resection in combination with post-operative multi-agent chemotherapy. This announcement follows the October 25, 2006 submission of a New Drug Application (NDA) for Junovan (mifamurtide for injection) to the Food and Drug Administration (FDA) in the United States.

HIV :: An AIDS-related virus tricks cells to become tumors, new Penn study finds

Researchers at the University of Pennsylvania School of Medicine have discovered how the Kaposi’s sarcoma-associated herpesvirus (KSHV) subverts a normal cell process in order to promote tumor growth. The finding, published in the most recent issue of PLoS Pathogens, offers new potential strategies for treating Kaposi’s sarcoma and other cancers associated with viruses

Health :: Drama night to show disabled talent

How do the disabled conquer their physical and mental constraints to step on the stage and perform drama, dance and music? Come and see the International Festival of Inclusive Arts’ drama night and you will get the answer.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack